PSEUDORESISTANCE OF PSEUDOMONAS-AERUGINOSA RESULTING FROM DEGRADATION OF IMIPENEM IN AN AUTOMATED SUSCEPTIBILITY TESTING SYSTEM WITH PREDRIED PANELS

被引:33
作者
WHITE, RL [1 ]
KAYS, MB [1 ]
FRIEDRICH, LV [1 ]
BROWN, EW [1 ]
KOONCE, JR [1 ]
机构
[1] MED UNIV S CAROLINA,DEPT PATHOL & LAB MED,DIV CLIN MICROBIOL,CHARLESTON,SC 29425
关键词
D O I
10.1128/JCM.29.2.398-400.1991
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During the use of a single lot of custom breakpoint panels (Sensititre; Radiometer America Inc., Westlake, Ohio), imipenem susceptibility declined from 70 to 44% for clinical isolates of Pseudomonas aeruginosa. With a new lot, susceptibility increased to 73%. Subsequent evaluations with P. aeruginosa ATCC 27853 revealed a similar susceptibility pattern and an increase in the MIC of imipenem when determined in panels with increasing ages. Imipenem concentrations were determined by high-performance liquid chromatography by using 11 different lots of MIC and breakpoint panels (139 to 893 days of age). The amount of imipenem remaining declined from 94.4 to 13.8% (r = 0.9225) over the age range of the panels. These data suggest that imipenem in Sensititre MIC and breakpoint panels degrades over time and that the decrease in imipenem may be largely responsible for the decline in P. aeruginosa susceptibility.
引用
收藏
页码:398 / 400
页数:3
相关论文
共 20 条
[1]   BIOACTIVITY OF IMIPENEM AS A FUNCTION OF MEDIUM, TIME, AND TEMPERATURE [J].
BARON, EJ ;
HINDLER, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (06) :781-782
[2]  
BARRY AL, 1985, DIAGN MICROBIOL INFE, V3, P963
[3]   COMPARATIVE INVITRO ACTIVITY OF MK0787 (N-FORMIMIDOYL THIENAMYCIN) AGAINST 540 BLOOD CULTURE ISOLATES [J].
COHN, DL ;
REIMER, LG ;
RELLER, LB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 9 (03) :183-194
[4]   INVITRO ANTIBACTERIAL ACTIVITY OF SM-7338, A CARBAPENEM ANTIBIOTIC WITH STABILITY TO DEHYDROPEPTIDASE-I [J].
EDWARDS, JR ;
TURNER, PJ ;
WANNOP, C ;
WITHNELL, ES ;
GRINDEY, AJ ;
NAIRN, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :215-222
[5]   MK0787 (N-FORMIMIDOYL THIENAMYCIN) - EVALUATION OF INVITRO AND INVIVO ACTIVITIES [J].
KROPP, H ;
SUNDELOF, JG ;
KAHAN, JS ;
KAHAN, FM ;
BIRNBAUM, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) :993-1000
[6]   EMERGENCE OF RESISTANCE TO IMIPENEM IN PSEUDOMONAS-AERUGINOSA [J].
LYNCH, MJ ;
DRUSANO, GL ;
MOBLEY, HLT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1892-1896
[7]   EFFECTS OF STORAGE-TEMPERATURE AND PH ON THE STABILITY OF 11 BETA-LACTAM ANTIBIOTICS IN MIC TRAYS [J].
NICKOLAI, DJ ;
LAMMEL, CJ ;
BYFORD, BA ;
MORRIS, JH ;
KAPLAN, EB ;
HADLEY, WK ;
BROOKS, GF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (03) :366-370
[8]   DEVELOPMENT OF RESISTANCE IN PSEUDOMONAS-AERUGINOSA TO IMIPENEM, NORFLOXACIN, AND CIPROFLOXACIN DURING THERAPY - PROOF PROVIDED BY TYPING WITH A DNA PROBE [J].
OGLE, JW ;
RELLER, LB ;
VASIL, ML .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) :743-748
[9]   EMERGENCE OF RESISTANCE TO IMIPENEM DURING THERAPY FOR PSEUDOMONAS-AERUGINOSA INFECTIONS [J].
QUINN, JP ;
DUDEK, EJ ;
DIVINCENZO, CA ;
LUCKS, DA ;
LERNER, SA .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (02) :289-294
[10]   CLINICAL OUTCOME OF NOSOCOMIAL PNEUMONIA FOLLOWING IMIPENEM CILASTATIN THERAPY [J].
RAPP, RP ;
YOUNG, B ;
BERTCH, K ;
TIBBS, P ;
FOSTER, TS .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (03) :272-276